Similarly, increased S100A6 expression was associated with a survival benefit for non-small cell lung cancers [35]; S100A6 was demonstrated in 2 lung cancer patients' sera, and in the pleural effusion of one. The gene discussed is S100A6; the disease is lung cancer.